The genetic basis of macrolide resistance was investigated in a collection of 48 genotypically unrelated clinical isolates of Streptococcus pneumoniae obtained between 1987 and 1997 in France. All strains were resistant to erythromycin, clindamycin, and streptogramin B, exhibiting a macrolide-lincosamide-streptogramin B resistance phenotype, and harbored the erm(B) gene. None of the strains carried the mef(A) or erm(A) subclass erm(TR) gene.
Forty-eight invasive strains of S. pneumoniae resistant to erythromycin by the disk diffusion method were collected throughout France between 1987 and 1997. The 48 isolates were previously shown to be of different clonal origins by means of restriction fragment length polymorphism analysis of the rRNA gene regions and of the pbp2b and 2x genes (9). The serotypes were 6B (n ϭ 10), 6A (n ϭ 4), 19A (n ϭ 1), 14 (n ϭ 9), 15A (n ϭ 3), 24 (n ϭ 2), 23F (n ϭ 9), and 19F (n ϭ 9); one strain was nontypeable. The MICs of erythromycin, azithromycin, josamycin, clindamycin, streptogramin B, and penicillin G were determined by the agar dilution method, using MuellerHinton medium supplemented with 5% sheep blood and incubation in room air (7) .
The mef and erm genes were detected after PCR amplification, as previously described (4, 12, 18, 20) . Streptococcus pyogenes 02C 1061, S. pyogenes 02C 1110, and S. pyogenes 02C 1064 were used as positive PCR controls for the erm(B), erm(A) subclass erm(TR), and mef(A) genes, respectively (4-6).
The 48 pneumococcal isolates displayed a high level of re-sistance to erythromycin and related agents ( (8, 11, 24) . This erythromycin resistance is associated with the M phenotype and the mef(A) gene in 56 to 63% of cases (11, 19, 24) . In South Africa the prevalence of erythromycin-resistant pneumococci with the M phenotype has increased from 1 to 20% in the last 10 years (26) . In Western Europe the prevalence of pneumococcal macrolide resistance varies geographically (1, 17; Felmingham et al., 40th ICAAC). Mechanisms of resistance have been investigated in countries with high prevalence rates. In Spain, 98% of erythromycin-resistant strains were found to have the MLS B phenotype (2) . In Italy and Belgium, more than 90% of strains carried the erm(B) gene (13, 16) . The spread of multiresistant clonal epidemic pneumococcal strains has been recently reported in France (9) . To avoid biasing our results, we determined the genetic mechanisms of macrolide resistance only in genotypically unrelated isolates, which were representative of the strains usually recovered in France during that period (9 
